Literature DB >> 6642676

The effect of piperacillin prophylaxis on the colonic microflora In patients undergoing colorectal surgery.

L Kager, A S Malmborg, C E Nord, S Sjöstedt.   

Abstract

Piperacillin was given parenterally in doses of 4 g every 8 h for two days to 20 patients undergoing colorectal surgery. A series of serum and fecal specimens were taken to analyse piperacillin concentrations. Tissue samples from the gut wall were taken during surgery. The maximum serum concentrations during surgery were reached 15 min after piperacillin administration. On Day 0 the mean half-life was 1.9 h and the mean area under the serum concentration curve was 536.8 mg/l. The piperacillin concentrations in the tissue samples ranged from 4.2 to 103.5 mg/kg. The tissue/serum ratio was 0.45. The piperacillin concentrations in the fecal samples ranged from not detectable to 101.2 mg/kg. Fecal samples were also collected during the investigation period for the cultivation of aerobic and anaerobic bacteria. Of the aerobic bacteria, enterococci, streptococci and enterobacteria decreased in on fourth of the patients during the prophylaxis period. Anaerobic bacteria, e. g. cocci, gram-positive rods, fusobacteria and bacteroides, decreased in two thirds of the patients during the same period. After the piperacillin administration period, the aerobic and anaerobic colon microflora returned to the pre-treatment pattern in most patients. Postoperative infections due to Escherichia coli, Morganella morganii, Bacteroides fragilis, peptococci and peptostreptococci occurred in two patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6642676     DOI: 10.1007/BF01641255

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  Ceftriaxone: renal and biliary excretion and effect on the colon microflora.

Authors:  A Arvidsson; G Alván; B Angelin; O Borgå; C E Nord
Journal:  J Antimicrob Chemother       Date:  1982-09       Impact factor: 5.790

2.  Pharmacokinetics of piperacillin following intravenous administration.

Authors:  M A Evans; P Wilson; T Leung; J D Williams
Journal:  J Antimicrob Chemother       Date:  1978-05       Impact factor: 5.790

3.  Colonization resistance of the digestive tract: clinical consequences and implications.

Authors:  D van der Waaij
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

4.  Comparative evaluation of piperacillin in vitro.

Authors:  G M Dickinson; T J Cleary; T A Hoffman
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

5.  Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man.

Authors:  A Heimdahl; C E Nord
Journal:  Scand J Infect Dis       Date:  1979

6.  Impact of cefoperazone therapy on fecal flora.

Authors:  M E Mulligan; D M Citron; B T McNamara; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

7.  Clostridium difficile and antibiotic associated diarrhoea in Sweden.

Authors:  B Aronsson; R Möllby; C E Nord
Journal:  Scand J Infect Dis Suppl       Date:  1982

8.  Effect of clindamycin prophylaxis on the colonic microflora in patients undergoing colorectal surgery.

Authors:  L Kager; L Liljeqvist; A S Malmborg; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

9.  Antibiotic prophylaxis with cefoxitin in colorectal surgery: effect on the colon microflora and septic complications--a clinical model for prediction of the benefit and risks in using a new antibiotic in prophylaxis.

Authors:  L Kager; I Ljungdahl; A S Malmborg; C E Nord; R Pieper; P Dahlgren
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

10.  Piperacillin distribution into bile, gallbladder wall, abdominal skeletal muscle, and adipose tissue in surgical patients.

Authors:  J Russo; M I Thompson; M E Russo; B A Saxon; J M Matsen; F G Moody; L F Rikkers
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

View more
  9 in total

1.  Imipenem concentrations in colorectal surgery and impact on the colonic microflora.

Authors:  L Kager; B Brismar; A S Malmborg; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

2.  Impact of injectable cephalosporins on the gastrointestinal microflora: observations in healthy volunteers and hospitalized patients.

Authors:  H Knothe; G A Dette; P M Shah
Journal:  Infection       Date:  1985       Impact factor: 3.553

Review 3.  Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers.

Authors:  S L Gorbach; M Barza; M Giuliano; N V Jacobus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

4.  Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans.

Authors:  M Giuliano; M Barza; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

5.  Effect of broad-spectrum parenteral antibiotics on "colonization resistance" of intestinal microflora of humans.

Authors:  M Barza; M Giuliano; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

6.  Suppression of colonic microflora by cefoperazone and evaluation of the drug as potential prophylaxis in bowel surgery.

Authors:  M Silva; N A Cornick; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 7.  Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; D M Richards; R N Brogden; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

Review 8.  Impact of antimicrobial therapy on the gut microbiome.

Authors:  Amira A Bhalodi; Tjitske S R van Engelen; Harjeet S Virk; W Joost Wiersinga
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

9.  Effects of treatment with antimicrobial agents on the human colonic microflora.

Authors:  Fatemeh Rafii; John B Sutherland; Carl E Cerniglia
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.